About Lapam Capital
Lapam Capital is a venture capital firm founded in 2011. It is primarily based out of Beijing, China. As of May 2025, Lapam Capital is an active investor, having invested in 13 companies, with 4 new investments in the last 12 months. It primarily invests in Series A round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to High Tech and HealthTech. Most recently it led the $20M Series A round of LTZ Therapeutics along with K2VC. This round also saw participation from and other investors.
Overall, Lapam Capital portfolio has seen 1 IPO, namely Suzhou Connect Biopharmaceuticals. A lot of funds co-invest with Lapam Capital, with names like Deyi Capital sharing a substantial percentage of its portfolio.
Lapam Capital has team of 1 people including 1 partners.
Key Metrics
Team Members
&
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series B, Series A &
Portfolio IPOs
Portfolio Soonicorns
Deals in last 12 months
Lapam Capital's Year-on-Year Investment Trends
Lapam Capital has invested in 13 companies over the last 12 years, with an average of 1 new investment annually in the last 10 years. In 2024, it made 3 investments, while as of May 2025, it has made 1 investment in this year. Its most recent first time investment was in EnChannel Medical.
Year | No. of Investments | ||
---|---|---|---|
1stÌý¸é´Ç³Ü²Ô»å | Follow-on | Total | |
2025 (YTD) | 1 | 0 | 1 |
2024 | 3 | 0 | 3 |
2023 | 0 | 0 | 0 |
2022 | 4 | 0 | 4 |
2021 | 2 | 0 | 2 |
2020 | 1 | 0 | 1 |
2019 | 0 | 0 | 0 |
2018 | 0 | 0 | 0 |
2017 | 1 | 0 | 1 |

Get Lapam Capital's portfolio delivered to your inbox!
Lapam Capital's Investment Trends by Stage
Lapam Capital has made 5 investments in Series B stage, 4 investments in Series A stage, 2 investments in Seed stage and 2 investments in Series C stage.Lapam Capital's Investment Trends by Sector
Lapam Capital has a diverse portfolio, with companies operating in the Life Sciences, High Tech, HealthTech, Healthcare and Sustainability Tech. Notably, it has invested in 12 Tech companies, 11 Enterprise (B2B) companies and 1 Tech hardware company.
Note: We have considered here, only first round of investments
Sector | No. of Investments |
---|---|
Life Sciences | 12 |
High Tech | 2 |
HealthTech | 1 |
Healthcare | 1 |
Sustainability Tech | 1 |
Lapam Capital's Investment Trends by Geography
Lapam Capital has made most investments in United States (7), followed by China where it has made 6 investments.
Lapam Capital's recent investments
Here are the most recent investments by Lapam Capital:
Date | Company | Location | Round Details | Round Amount | Co-Investors |
---|---|---|---|---|---|
May 01, 2025 | United States | Series B | $82.2M | [+1] | |
Jul 30, 2024 | United States | Series A | $20M | Shunwei Capital [+4] | |
Jul 26, 2024 | United States | Series A | $30M | CDH [+4] | |
Jun 20, 2024 | United States | Series A | $28M | ||
Sep 29, 2022 | China | Seed | Undisclosed |
Team profile of Lapam Capital
Lapam Capital has a team of 1 member. Lapam Capital's team does not sit on the board of any company as of now.Co-investors of Lapam Capital
Over the past 12 years, 59 investors have co-invested in Lapam Capital's portfolio companies.
- Invested before Lapam Capital:ÌýShunwei Capital, Kaitai Capital Management and 19 others have invested in rounds before Lapam Capital. There are 2 companies where Shunwei Capital has invested before Lapam Capital and 1 company where Kaitai Capital Management has invested before Lapam Capital.
- Top Co-investors of Lapam Capital:Ìý32 investors entered a company along with Lapam Capital. These include investors like Deyi Capital (2 companies).
- Invested after Lapam Capital:ÌýA total of 6 investors have invested in Lapam Capital's portfolio after their investments. Top Investors include RA Capital Management (1 company), (1 company) and Boxer Capital (1 company).

Get full list of Lapam Capital's co-investors delivered to your inbox!
Recent News related to Lapam Capital
•
•
•
•
•
•
•
•
PR Newswire•Jul 27, 2022•BridGene Biosciences, Lapam Capital, Junson Capital, Deyi Capital and 1 other
•
•